FDA approves drug for infantile-onset Niemann-Pick type C after analysis finds longer survival

Regulatory Approvals — FDA approves drug for infantile-onset Niemann-Pick type C after analysis finds longer survival  Medical Xpress

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 18, 2026.

By